PERI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 29.770
EU - Europa 14.355
AS - Asia 2.825
SA - Sud America 28
AF - Africa 19
Continente sconosciuto - Info sul continente non disponibili 18
OC - Oceania 14
Totale 47.029
Nazione #
US - Stati Uniti d'America 29.477
DE - Germania 5.423
DK - Danimarca 2.795
IT - Italia 2.021
CN - Cina 1.121
SE - Svezia 825
SG - Singapore 697
IE - Irlanda 621
RU - Federazione Russa 542
UA - Ucraina 483
GB - Regno Unito 363
HK - Hong Kong 342
PL - Polonia 337
FR - Francia 283
CA - Canada 282
VN - Vietnam 278
AT - Austria 201
FI - Finlandia 160
ID - Indonesia 108
IN - India 93
BE - Belgio 83
NL - Olanda 74
TR - Turchia 64
ES - Italia 43
JP - Giappone 41
RO - Romania 30
IR - Iran 24
CH - Svizzera 16
BR - Brasile 15
EU - Europa 12
PK - Pakistan 12
LT - Lituania 11
AU - Australia 10
GR - Grecia 10
IL - Israele 10
CZ - Repubblica Ceca 8
MX - Messico 8
TW - Taiwan 8
EG - Egitto 6
MY - Malesia 6
BG - Bulgaria 5
KR - Corea 5
MU - Mauritius 5
NO - Norvegia 5
PH - Filippine 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AR - Argentina 4
BD - Bangladesh 4
CL - Cile 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
AE - Emirati Arabi Uniti 3
EC - Ecuador 3
HU - Ungheria 3
SC - Seychelles 3
A1 - Anonimo 2
ET - Etiopia 2
LV - Lettonia 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CR - Costa Rica 1
CU - Cuba 1
EE - Estonia 1
GL - Groenlandia 1
HR - Croazia 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
ME - Montenegro 1
MK - Macedonia 1
NG - Nigeria 1
OM - Oman 1
TN - Tunisia 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 47.029
Città #
Ann Arbor 19.992
Frankfurt am Main 5.121
Woodbridge 1.150
Wilmington 1.090
Chandler 942
Fairfield 884
Milan 642
Dublin 596
Houston 589
Singapore 577
Ashburn 572
Jacksonville 503
Seattle 357
Hong Kong 335
Kraków 329
Dearborn 310
Santa Clara 281
Cambridge 268
Rome 245
Princeton 232
Dong Ket 220
Vienna 193
Nanjing 183
New York 144
Boardman 139
Shanghai 133
Altamura 131
Beijing 112
Guangzhou 110
Lawrence 107
Jakarta 104
Toronto 89
Brussels 82
Lachine 80
San Diego 78
Helsinki 58
Florence 50
Ottawa 49
Fremont 44
Falls Church 42
Jinan 41
Montréal 39
Tianjin 39
Hebei 38
Andover 36
Nanchang 36
Shenyang 34
Hangzhou 31
Changsha 30
Huizen 29
Norwalk 28
Jiaxing 25
Mountain View 25
London 24
Los Angeles 21
Monza 20
Kunming 19
Turin 18
Duncan 17
Zhengzhou 17
Chicago 16
Edmonton 16
Munich 16
Redmond 16
Grafing 14
Tokyo 14
University Park 14
Cinisello Balsamo 13
Kiev 13
Ningbo 13
Paris 13
Taiyuan 13
Washington 13
Brescia 12
Haikou 12
Kocaeli 12
Leawood 12
Pune 12
Romola 12
Amsterdam 11
Berlin 11
Como 11
Napoli 11
Auburn Hills 10
Hefei 10
Lappeenranta 10
Monmouth Junction 10
São Paulo 10
Taizhou 10
Brunswick 9
Carate Brianza 9
Donostia / San Sebastian 9
Naples 9
Padova 9
Phoenix 9
Saint Petersburg 9
Trieste 9
Bengaluru 8
Clearwater 8
Iasi 8
Totale 38.186
Nome #
Novel carboxylate-based glycolipids: TLR4 antagonism, MD-2 binding and self-assembly properties 684
Toll-like receptor 4 modulation influences human neural stem cell proliferation and differentiation 654
Structural characterization of aerogels derived from enzymatically oxidized galactomannans of fenugreek, sesbania and guar gums 649
Structure–Activity Relationship in Monosaccharide-Based Toll-Like Receptor 4 (TLR4) Antagonists 619
Synthetic and natural small molecule TLR4 antagonists inhibit motoneuron death in cultures from ALS mouse model 601
Selective cytotoxicity of a bicyclic Ras inhibitor in cancer cells expressing K-RasG13D 568
Recent advances on Toll-like receptor 4 modulation: new therapeutic perspectives 564
Amphiphilic Guanidinocalixarenes Inhibit Lipopolysaccharide (LPS)-and Lectin-Stimulated Toll-like Receptor 4 (TLR4) Signaling 550
Dye-sensitized photocatalytic hydrogen production: Distinct activity in a glucose derivative of a phenothiazine dye 545
First experimental identification of Ras-inhibitor binding interface using a water-soluble Ras ligand 538
Co-administration of Antimicrobial Peptides Enhances Toll-like Receptor 4 Antagonist Activity of a Synthetic Glycolipid 526
TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection 525
Dye-Sensitized Photocatalytic Hydrogen Generation: Efficiency Enhancement by Organic Photosensitizer-Coadsorbent Intermolecular Interaction 523
Glucose-derived Ras pathway inhibitors: evidence of Ras-ligand binding and Ras-GEF (Cdc25) interaction inhibition 517
Binding properties and biological characterization of new sugar-derived Ras ligands 514
Metabolism of Phosphatidylinositol 4-Kinase IIIα-Dependent PI4P Is Subverted by HCV and Is Targeted by a 4-Anilino Quinazoline with Antiviral Activity 501
Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors 500
Modulation of CD14 and TLR4·MD-2 activities by a synthetic lipid A mimetic 500
The role of carbohydrates in the lipopolysaccharide (LPS)/toll-like receptor 4 (TLR4) Signalling 499
Structure and inflammatory activity of the LPS isolated from Acetobacter pasteurianus CIP103108 491
Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors 484
Glycolipids and benzylammonium lipids as novel antisepsis agents: Synthesis and biological characterization 479
How do viruses interfere with Toll-like receptor 4? 477
Toll-like Receptor 4 (TLR4) Modulation by Synthetic and Natural Compounds: An Update 476
Glial TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice 473
Synthesis and biological evaluation of novel lipid A antagonists 473
Functional characterization of E. coli LptC: Interaction with LPS and a synthetic ligand 468
Uniform Lipopolysaccharide (LPS)-Loaded Magnetic Nanoparticles for the Investigation of LPS–TLR4 Signaling 467
Exploring the LPS/TLR4 signal pathway with small molecules 463
Synthesis of the New Cyanine-Labeled Bacterial Lipooligosaccharides for Intracellular Imaging and in Vitro Microscopy Studies 461
A Synthetic Lipid A Mimetic Modulates Human TLR4 Activity 458
A new isoluminol reagent for chemiluminescence labeling of proteins 457
Trehalose- and glucose-derived glycoamphiphiles: Small-molecule and nanoparticle toll-like receptor 4 (TLR4) modulators 456
Glycolipid-based TLR4 Modulators and Fluorescent Probes: Rational Design, Synthesis, and Biological Properties 456
Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists 454
The synthetic glycolipid-based TLR4 antagonist FP7 negatively regulates in vitro and in vivo haematopoietic and non-haematopoietic vascular TLR4 signalling 454
Effect of chemical modulation of toll-like receptor 4 in an animal model of ulcerative colitis 450
The Multi-Level Mechanism of Action of a Pan-Ras Inhibitor Explains its Antiproliferative Activity on Cetuximab-Resistant Cancer Cells 446
Synthetic molecules and functionalized nanoparticles targeting the LPS-TLR4 signaling: a new generation of immunotherapeutics 440
Inhibition of lipid A stimulated activation of human dendritic cells and macrophages by amino and hydroxylamino monosaccharides 438
Sugar-derived Ras inhibitors: group epitope mapping by NMR spectroscopy and biological evaluation 438
Clustered carbohydrates in synthetic vaccines 435
Design and characterisation of a new class of inhibitors of Ras activation 434
Multivalent glycoconjugates as anti-pathogenic agents 433
Hemin and a metabolic derivative coprohemin modulate the TLR4 pathway differently through different molecular targets 432
Modulation of LPS signaling through TLR4 agonists and antagonists 431
Compound for the covalent attachment of the chemiluminescent probe N-(4-Aminobutyl)-N-ethylisoluminol (ABEI) to target molecules and uses thereof 431
Design, synthesis and biological evaluation of sugar-derived Ras inhibitors 430
Design, Synthesis and Biological Evaluation of Levoglucosenone-derived Ras Activation Inhibitors 429
The cationic amphiphile 3,4-bis (tetradecyloxy) benzylamine inhibits LPS signaling by competing with endotoxin for CD14 binding 423
Carbohydrate-based bioactive compounds for medicinal chemistry applications 421
TLR4 signaling pathway modulators as potential therapeutics in inflammation and sepsis 421
Optimizing operating conditions and electrochemical characterization of glucose–gluconate alkaline fuel cells 418
Arabinose-derived Bicyclic Amino Acids: Synthesis, Conformational Analysis and Construction of an avb3-selective RGD Peptide 417
Editorial 417
Rigid polycycles and peptidomimetics from carbohydrate synthons 414
Evidence of a specific interaction between new synthetic antisepsis agents and CD14 412
Looking forward: A glance into the future of organic chemistry 401
Chemoselective neoglycosylation 401
Chemistry of lipid a: At the heart of innate immunity 397
Glycoconjugates in cancer therapy 396
A novel small molecule TLR4 antagonist (IAXO-102) negatively regulates non-hematopoietic toll like receptor 4 signalling and inhibits aortic aneurysms development 394
Sugar-derived amino acids: powerful secondary structure inducing elements in the design of novel peptidomimetics 390
Novel α-conotoxin from Conus spurius and the α-conotoxin EI share high-affinity potentiation and low-affinity inhibition of nicotinic acetylcoline receptors 388
Extending chemoselective ligation to sugar chemistry:convergent assembly of bioactive neoglycoconjugates 388
Studies on the mechanism of action of a new class of inhibitors of Ras activation 388
Sugar-Based Inhibitors of Ras Activation: Biological Activity and Identification of Ras–Inhibitor Binding Interface 388
Polycyclic Scaffolds from Fructose 387
Solution and solid-phase chemoselective synthesis of (1-6)-amino(methoxy) di- and trisaccharide analogues 386
Assembly of binding loops on aromatic templates as V CAM-1 mimetics 385
Glycoconjugate and oligosaccharide mimetics by chemoselective ligation 381
Discrimination Properties of Tetraamidic Branched Selectors 380
Chemoselective glycosylation techniques for the synthesis of bioactive neoglycoconjugates, glyconanoparticles and glycoarrays 380
Carbohydrate Scaffolds for the Production of Bioactive Compounds 377
Chemoselective Ligation in Glycochemistry 377
Stepwise synthesis and structural characterization of calix[4]- and calix[5]arenes bearing a functionalized arm on the methylene bridge 376
Synthesis of imino sugar scaffolds for the generation of glycosidase inhibitor libraries 375
The EuroSciCon's 2015 Innate Immunity Summit 375
Synthesis and biological evaluation of an anticancer vaccine containing the C-glycoside analogue of the Tn epitope 374
Carbohydrate-based Scaffolds for the generation of sortiments of bioactive compounds 365
Synthesis of imino-C-disaccharides related to sucrose 364
Clicked and long spaced galactosyl- and lactosylcalix[4]arenes: New multivalent galectin-3 ligands 364
Stereoselective synthesis of α-C-glycosides of N-acetylgalactosamine 362
A new procedure for the synthesis of C-glycosides of nojirimycin 361
Bicyclic carbohydrate-derived scaffolds for combinatorial libraries 360
The bone morphogenic protein antagonist Drm/gremlin is a novel pro- angiogenic factor 356
Synthesis of bicyclic sugar azido acids and their incorporation in cyclic peptides 354
Conversion of lactose into mimics of N-acetyllactosamine 352
Regioselection and orthogonality of the 1-phenyl-3-butenyl (PBU) protecting group in glucopyranosides 348
Glycidic scaffolds in Peptidomimetic synthesis 346
Chemo- and stereoselective glycosylation of hydroxylamino derivatives: A versatile approach to glycoconjugates 344
D-glucose as a regioselectively addressable scaffold for combinatorial chemistry on solid phase 344
Synthesis and conformational analysis of novel N(OCH3) disaccharide analogues 343
Lipid A antagonists with anti-septic shock, anti-inflammatory, anti-ischemia and analgesic activity 342
On the regioselectivity of the protease subtilisin towards the acylation of enantiomeric pairs of benzyl and naphthyl glycopyranosides. Part 2 342
The Role of TLR4 in Neural Stem Cells–Mediated Neurogenesis and Neuroinflammation 340
Conformational features of a synthetic model of the first extracellular loop of the angiotensin II AT1A receptor 336
Enzyme Mediated Acylation of Benzyl Beta D and L-Glucopiranoside: A Remarkable Example of Enantiomeric Recognition by Regioselective Transformation 335
Fused oxabicyclic aminoalcohols as new scaffolds for combinatorial libraries 327
Developing New Anti-Tuberculosis Vaccines: Focus on Adjuvants 327
Totale 43.330
Categoria #
all - tutte 104.992
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.992


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.157 0 0 0 0 0 343 448 610 910 989 1.010 847
2020/202112.003 1.070 730 891 1.144 942 978 1.033 1.187 911 1.052 816 1.249
2021/202211.080 1.142 1.083 967 1.112 887 869 785 847 676 868 787 1.057
2022/20238.296 1.376 1.724 1.100 997 928 1.111 161 295 250 175 104 75
2023/20242.842 84 188 345 160 351 433 448 141 184 86 110 312
2024/20252.381 324 548 455 326 461 267 0 0 0 0 0 0
Totale 48.367